Asperlin is a marine-derived, orally active small molecule with broad bioactivity. It induces apoptosis, ROS generation, and DNA damage-mediated G2/M arrest in vitro, and modulates gut microbiota to counteract HFD-induced obesity in vivo, supporting research in oncology, immunology, and metabolic disease.